(ALAB) Astera Labs, Common Stock - Ratings and Ratios
Retimers, Controllers, Switches, Modules, Software
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 93.9% |
| Value at Risk 5%th | 131% |
| Relative Tail Risk | -15.18% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.65 |
| Alpha | -18.53 |
| CAGR/Max DD | 2.03 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.470 |
| Beta | 2.378 |
| Beta Downside | 2.234 |
| Drawdowns 3y | |
|---|---|
| Max DD | 63.69% |
| Mean DD | 28.54% |
| Median DD | 32.40% |
Description: ALAB Astera Labs, Common Stock December 03, 2025
Astera Labs (NASDAQ: ALAB) is a U.S.–based semiconductor firm founded in 2017 that develops and sells connectivity solutions aimed at cloud-computing and artificial-intelligence (AI) infrastructure.
The company’s core offering is an “intelligent connectivity platform” that combines mixed-signal chips (including microcontrollers and sensors) with its COSMOS software suite, which provides link-level, fleet-wide, and reliability-aware (RAS) management for large-scale data-center deployments.
Product lines include PCIe/CXL smart retimers, Ethernet smart cable modules, CXL memory controllers, and smart fabric switches-components that enable high-bandwidth, low-latency communication between CPUs, GPUs, and accelerators in hyperscaler and OEM systems.
Industry data (as of Q3 2024) shows the data-center connectivity market expanding at ~12% CAGR, driven by rising AI workloads and the adoption of CXL as a standard for memory pooling; Astera Labs reported a year-over-year revenue increase of ~68% in its most recent filing, and its gross margin has stabilized around 55%, reflecting scaling of its high-value retimer products.
For a deeper, data-driven assessment of ALAB’s valuation relative to sector peers, you may find ValueRay’s analytical dashboard worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (198.9m TTM) > 0 and > 6% of Revenue (6% = 43.4m TTM) |
| FCFTA 0.16 (>2.0%) and ΔFCFTA 7.06pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 164.5% (prev 280.5%; Δ -116.0pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.19 (>3.0%) and CFO 263.7m > Net Income 198.9m (YES >=105%, WARN >=100%) |
| Net Debt (-109.1m) to EBITDA (123.1m) ratio: -0.89 <= 3.0 (WARN <= 3.5) |
| Current Ratio 12.78 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (180.6m) change vs 12m ago 15.18% (target <= -2.0% for YES) |
| Gross Margin 75.41% (prev 77.62%; Δ -2.21pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 60.65% (prev 31.10%; Δ 29.55pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -3.70 (EBITDA TTM 123.1m / Interest Expense TTM -31.9m) >= 6 (WARN >= 3) |
Altman Z'' 5.90
| (A) 0.85 = (Total Current Assets 1.29b - Total Current Liabilities 101.0m) / Total Assets 1.40b |
| (B) -0.02 = Retained Earnings (Balance) -34.6m / Total Assets 1.40b |
| (C) 0.10 = EBIT TTM 118.1m / Avg Total Assets 1.19b |
| (D) -0.24 = Book Value of Equity -30.5m / Total Liabilities 129.5m |
| Total Rating: 5.90 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 75.45
| 1. Piotroski 5.0pt |
| 2. FCF Yield 0.85% |
| 3. FCF Margin 31.73% |
| 4. Debt/Equity 0.02 |
| 5. Debt/Ebitda -0.89 |
| 6. ROIC - WACC (= -0.08)% |
| 7. RoE 18.02% |
| 8. Rev. Trend 90.96% |
| 9. EPS Trend 85.98% |
What is the price of ALAB shares?
Over the past week, the price has changed by -9.44%, over one month by -2.68%, over three months by -27.87% and over the past year by +25.37%.
Is ALAB a buy, sell or hold?
- Strong Buy: 9
- Buy: 7
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ALAB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 197.3 | 21.3% |
| Analysts Target Price | 197.3 | 21.3% |
| ValueRay Target Price | 186.3 | 14.6% |
ALAB Fundamental Data Overview January 09, 2026
P/E Forward = 70.922
P/S = 38.7243
P/B = 22.0166
Beta = None
Revenue TTM = 723.0m USD
EBIT TTM = 118.1m USD
EBITDA TTM = 123.1m USD
Long Term Debt = 1.29m USD (from capitalLeaseObligations, last fiscal year)
Short Term Debt = 4.44m USD (from shortTermDebt, last quarter)
Debt = 31.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -109.1m USD (from netDebt column, last quarter)
Enterprise Value = 26.90b USD (28.00b + Debt 31.3m - CCE 1.13b)
Interest Coverage Ratio = -3.70 (Ebit TTM 118.1m / Interest Expense TTM -31.9m)
EV/FCF = 117.2x (Enterprise Value 26.90b / FCF TTM 229.4m)
FCF Yield = 0.85% (FCF TTM 229.4m / Enterprise Value 26.90b)
FCF Margin = 31.73% (FCF TTM 229.4m / Revenue TTM 723.0m)
Net Margin = 27.50% (Net Income TTM 198.9m / Revenue TTM 723.0m)
Gross Margin = 75.41% ((Revenue TTM 723.0m - Cost of Revenue TTM 177.8m) / Revenue TTM)
Gross Margin QoQ = 76.25% (prev 75.84%)
Tobins Q-Ratio = 19.20 (Enterprise Value 26.90b / Total Assets 1.40b)
Interest Expense / Debt = -101.8% (Interest Expense -31.9m / Debt 31.3m)
Taxrate = -36.27% (negative due to tax credits) (-24.3m / 66.9m)
NOPAT = 160.9m (EBIT 118.1m * (1 - -36.27%)) [negative tax rate / tax credits]
Current Ratio = 12.78 (Total Current Assets 1.29b / Total Current Liabilities 101.0m)
Debt / Equity = 0.02 (Debt 31.3m / totalStockholderEquity, last quarter 1.27b)
Debt / EBITDA = -0.89 (Net Debt -109.1m / EBITDA 123.1m)
Debt / FCF = -0.48 (Net Debt -109.1m / FCF TTM 229.4m)
Total Stockholder Equity = 1.10b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.68% (Net Income 198.9m / Total Assets 1.40b)
RoE = 18.02% (Net Income TTM 198.9m / Total Stockholder Equity 1.10b)
RoCE = 10.69% (EBIT 118.1m / Capital Employed (Equity 1.10b + L.T.Debt 1.29m))
RoIC = 14.58% (NOPAT 160.9m / Invested Capital 1.10b)
WACC = 14.66% (E(28.00b)/V(28.03b) * Re(14.68%) + (debt cost/tax rate unavailable))
Discount Rate = 14.68% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 8.83%
[DCF Debug] Terminal Value 57.67% ; FCFF base≈174.3m ; Y1≈175.1m ; Y5≈187.2m
Fair Price DCF = 9.13 (EV 1.43b - Net Debt -109.1m = Equity 1.54b / Shares 168.9m; r=14.66% [WACC]; 5y FCF grow 0.0% → 2.90% )
EPS Correlation: 85.98 | EPS CAGR: 123.4% | SUE: 1.68 | # QB: 2
Revenue Correlation: 90.96 | Revenue CAGR: 118.2% | SUE: 3.54 | # QB: 3
EPS next Quarter (2026-03-31): EPS=0.52 | Chg30d=+0.001 | Revisions Net=+12 | Analysts=17
EPS next Year (2026-12-31): EPS=2.37 | Chg30d=+0.011 | Revisions Net=+13 | Growth EPS=+33.3% | Growth Revenue=+42.2%
Additional Sources for ALAB Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle